BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23276963)

  • 1. The autoimmunity in Graves's disease.
    Li H; Wang T
    Front Biosci (Landmark Ed); 2013 Jan; 18(2):782-7. PubMed ID: 23276963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
    Kristensen B
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
    Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
    Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders.
    Vitales-Noyola M; Ramos-Levi AM; Martínez-Hernández R; Serrano-Somavilla A; Sampedro-Nuñez M; González-Amaro R; Marazuela M
    Endocrine; 2017 Sep; 57(3):409-417. PubMed ID: 28669056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.
    Fang S; Lu Y; Huang Y; Zhou H; Fan X
    Front Endocrinol (Lausanne); 2021; 12():648732. PubMed ID: 33868176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Treg/Th17 cells and related cytokines in Graves' ophthalmopathy].
    Lv M; Shen J; Li Z; Zhao D; Chen Z; Wan H; Hao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1809-13. PubMed ID: 25537908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in thyroid autoimmunity.
    Ferrari SM; Paparo SR; Ragusa F; Elia G; Mazzi V; Patrizio A; Ghionzoli M; Varricchi G; Centanni M; Ulisse S; Antonelli A; Fallahi P
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101773. PubMed ID: 36907786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
    Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
    Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms.
    Ramos-Leví AM; Marazuela M
    Endocrinol Nutr; 2016 Oct; 63(8):421-9. PubMed ID: 27234136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
    Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
    Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thyroid, the eyes and the gut: a possible connection.
    Covelli D; Ludgate M
    J Endocrinol Invest; 2017 Jun; 40(6):567-576. PubMed ID: 28063079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulatory plasmacytoid dendritic cells selectively accumulate in perithyroidal lymph nodes of patients with Graves disease: implications for the understanding of autoimmunity.
    Hassan I; Brendel C; Zielke A; Burchert A; Danila R
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):46-51. PubMed ID: 24505891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity.
    Fallahi P; Ferrari SM; Corrado A; Giuggioli D; Ferri C; Antonelli A
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):95-101. PubMed ID: 24953644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Graves' disease focusing on Graves' ophthalmopathy.
    Karoutsou E; Polymeris A
    Endocr Regul; 2011 Oct; 45(4):209-20. PubMed ID: 22073951
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue.
    Mukuta T; Nishikawa M; Arreaza G; Resetkova E; Yoshikawa N; Fornasier V; Young E; Volpé R
    Thyroid; 1996 Oct; 6(5):429-36. PubMed ID: 8936667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases.
    Li C; Yuan J; Zhu YF; Yang XJ; Wang Q; Xu J; He ST; Zhang JA
    Cell Physiol Biochem; 2016; 40(1-2):245-252. PubMed ID: 27855396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' disease and Graves' orbitopathy following COVID-19.
    Lanzolla G; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Sep; 44(9):2011-2012. PubMed ID: 33964007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.